Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study

Journal of Postgraduate Medicine

Volumn 57, Issue 2, 2011, Pages 115-119

  Barvaliya, M ^a   Sanmukhani, J ^a   Patel, T ^a   Paliwal, N ^a   Shah, H ^a   Tripathi, C ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Adverse drug reaction; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CEFIXIME; CHLOROQUINE; COTRIMOXAZOLE; DICLOFENAC; DOMPERIDONE; ERYTHROMYCIN; FAMOTIDINE; GENTAMICIN; IMMUNOGLOBULIN; LEVOFLOXACIN; NEVIRAPINE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PANTOPRAZOLE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; QUININE; STAVUDINE; STEROID; ZIDOVUDINE;

ACUTE KIDNEY FAILURE; ANALYSIS OF VARIANCE; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG COST; DRUG INDUCED DISEASE; ELECTROLYTE DISTURBANCE; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INCUBATION TIME; LENGTH OF STAY; LEUKOCYTOSIS; LEUKOPENIA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SECONDARY INFECTION; SEPTICEMIA; STEVENS JOHNSON SYNDROME; STEVENS JOHNSON SYNDROME TOXIC EPIDERMAL NECROLYSIS OVELAP; STEVENS JOHNSON SYNDROME TOXIC EPIDERMAL NECROLYSIS OVERLAP; SYSTEMIC THERAPY; TERTIARY HEALTH CARE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; CHILD; DRUG TOXICITY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SEX DISTRIBUTION; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 80052229093     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.81865     Document Type: Article

References (22)

1. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: A prospective study. BMC Clin Pharmacol 2007;7:8.
2. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009;9:8.
3. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000;34:1373-9.
4. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents - a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95-9. (Pubitemid 34183129)
5. Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: An overview. J Postgrad Med 1996;42:15-22. (Pubitemid 126729327)
6. Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 2008;7:598-605.
7. Li LF, MaC. Epidemiological study of severe cutaneous adverse drug reactions in a city district in China. Clin Exp Dermatol 2006;31:642-7.
8. Khambaty MM, Hsu SS. Dermatology of the patient with HIV. Emerg Med Clin North Am 2010;28:355-68.
9. Mockenhaupt M. Severe drug-induced skin reactions: Clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 2009;7:142-60.
10. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital- their severity and cost involved. Pharmacoepidemiol drug saf 2003;12:687-92. (Pubitemid 38028783)
11. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: A severity-of-illness score of Toxic Epidermal Necrolysis. J Investi Dermatol 2000;112:149-53. (Pubitemid 30637181)
12. Naranjo CA, Busto U, Seller EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reaction. Clin. Pharmacol Ther 1981;30:239-55.
13. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome: An epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.
14. Sharma VK, Sethuraman G, Minz A. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: A retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol 2008;74:238-40. (Pubitemid 351918878)
15. Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine-the commonest cause of toxic epidermal necrolysis and Stevens- Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol 2005;71:325-8. (Pubitemid 41376754)
16. Wanat KA, Anadkat MJ, Klekotka PA. Seasonal variation of Stevens- Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim- sulfamethoxazole. J Am Acad Dermatol 2009;60:589-94.
17. Leenutaphong V, Sivayathorn A, Suthipinittharm P, Sunthonpalin P. Stevens-Johnson syndrome and toxic epidermal necrolysis in Thailand. Int J Dermatol 1993;32:428-31. (Pubitemid 23189890)
18. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001;15:1843-8. (Pubitemid 32939246)
19. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44. (Pubitemid 350249390)
20. Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. Am J Health Syst Pharm 2010;67:206-13.
21. Yap FBB, Wahiduzzaman M, Pubalan M. Stevens - Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) In Sarawak: A Four Years' Review. Egyptian Dermatol Online J 2008;04.
22. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens- Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87:144-8. (Pubitemid 46513200)